Related Experiment Videos
Paraneoplastic glomerulopathies
1Department of Internal Medicine, Texas Tech University School of Medicine, Lubbock 79430.
Seminars in Nephrology
|May 1, 1993
Summary
Cancer patients often develop immune complexes that can damage kidneys, leading to paraneoplastic glomerulopathy. Early cancer detection may improve outcomes for these patients.
Area of Science:
- Nephrology
- Oncology
- Immunology
Background:
- Neoplastic diseases expose patients to continuous antigenemia, stimulating antibody production and immune complex formation.
- These immune reactants can deposit in the glomeruli, leading to kidney damage.
- Proteinuria in cancer patients indicates a worse prognosis.
Purpose of the Study:
- To investigate the link between cancer and paraneoplastic glomerulopathy.
- To understand the clinical manifestations and prognosis of cancer-associated kidney disease.
Main Methods:
- Review of existing literature on cancer and renal disease.
- Analysis of clinical data from cancer patients with glomerular injury.
Main Results:
- Up to 80% of cancer patients experience antigenemia, potentially leading to immune complex deposition.
- Less than 1% of adult cancer patients develop overt paraneoplastic renal disease, most commonly Minimal Change Glomerulopathy (MCG).
- Successful cancer treatment can lead to remission of associated glomerulopathy, but overall prognosis remains poor.
Conclusions:
- Paraneoplastic glomerulopathy is a rare but serious complication of cancer.
- Early recognition and treatment of the underlying malignancy are crucial for managing associated kidney disease.
- Consideration of cancer screening in older patients with unexplained nephrotic syndrome is warranted.